Hepatitis B core antibody positivity and risk of hepatitis B reactivation following switch of antiretroviral therapy
AIDS
.
2025 Aug 1;39(10):1481-1483.
doi: 10.1097/QAD.0000000000004268.
Epub 2025 Jul 10.
Authors
Firouzé Bani-Sadr
1
,
Brian R Wood
2
Affiliations
1
Department of Internal Medicine, Infectious Diseases, and Clinical Immunology, Centre Hospitalier Universitaire, Reims, France.
2
Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
PMID:
40643082
DOI:
10.1097/QAD.0000000000004268
No abstract available